Tradestie Institutional Equity Comparison Engine

PMI vs RDN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

RDN Overall Edge

RDN Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Radian Group Inc. (RDN) driven by superior Valuation, Growth & Margin, Options & Structure while PMI counters with relative strength in Momentum & Technical. Fundamentally, PMI trades at N/M Forward P/E with -248.1% operating margin (+38.6% YoY revenue) versus RDN at 6.9x Forward P/E and 45.4% operating margin (+105.7% YoY). In options structure, PMI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against RDN sits in UNCLASSIFIED (5th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner RDN
PMI N/M vs RDN 6.9x Fwd P/E
Growth & Margin Winner RDN
Op Margin -248.1% vs 45.4% ยท YoY +38.6% vs +105.7%
Momentum & Technical Winner PMI
1Y +107.2% vs +5.8% ยท 52W Pos 34% vs 56%
Options & Structure Winner RDN
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (5th %ile IV)
PMI NYSE American
Picard Medical, Inc.
Surgical & Medical Instruments & Apparatus
$6.30
-2.17% 1D
Market Cap $17.1M
1M Return -34.58%
1Y Return +107.24%
Forward P/E N/M
Unified AI Score
48.4 / 100 HOLD
Tech 39.0 Fund 45.0 Flow 50.0 Mom 50.0
RDN NYSE
Radian Group Inc.
Surety Insurance
$36.47
-0.16% 1D
Market Cap $4.6B
1M Return +7.33%
1Y Return +5.77%
Forward P/E 6.9x
Unified AI Score
34.9 / 100 SELL
Tech 36.0 Fund 42.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PMI +107.24% RDN +5.77% Spread: +142.26 pp (PMI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
PMI TTM Op. Margin: -248.1% RDN TTM Op. Margin: 45.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PMI vs RDN. Trailing 12-month operating profitability (PMI -248.1% vs RDN 45.4%) and valuation multiples (PMI N/M vs RDN 6.9x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PMI (2) vs RDN (8)
Institutional Metric PMI RDN Criterion Row Winner
Market Capitalization Scale $17.1M $4.6B Larger Scale RDN
Trailing P/E Ratio Valuation 2.9x 8.7x Lower Multiple PMI
Forward P/E Ratio Valuation N/M 6.9x Lower Multiple RDN
Revenue Growth (YoY) Growth +38.6% +105.7% Higher Growth RDN
Operating Margin (TTM) Profitability -248.1% 45.4% Higher Margin RDN
Net Profit Margin Profitability 0.0% 28.3% Higher Margin RDN
Return on Equity (ROE) Capital Efficiency 0.0% 12.4% Higher ROE RDN
52-Week Range Position Momentum 34% ($0โ€“$18) 56% ($31โ€“$41) Stronger Trend RDN
Beta / 30D Volatility Risk Regime 54.06ฮฒ ยท 134% Vol -0.07ฮฒ ยท 26% Vol Lower Realized Risk RDN
Unified Institutional Score Composite Signal 48.4 / 100 (HOLD) 34.9 / 100 (SELL) Higher Composite PMI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PMI vs RDN Buy Guide
PMI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PMI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
RDN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live RDN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PMI nor RDN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.